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Abstract
Bulb extracts of Gladiolus dalenii reportedly used in the treatment of fungal infections in HIV/AIDS 
patients in the Lake Victoria region were tested for antifungal activity using the disc diffusion assay technique. 
Commercially used antifungal drugs, Ketaconazole and Griseofulvin (Cosmos Pharmaceuticals) were used as 
standards. Dichloromethane (CH2CL2)/Methanol (MeOH) in the ratio 1:1. Soluble extracts showed antifungal 
activity against Aspergillus niger. Direct bioautography on silica gel Thin Layer Chromatography (TLC) and 
appropriate spraying agents were used to identify the active component in the extract. The activities of both the 
extracts were higher than that of Griseofulvin. CH2CL2 soluble extract in addition showed ability to delay sporulation 
in A.niger. The active group of compounds in the extracts was identified as alkaloids, which offer immense potential 
for development of new and valuable pharmaceutical products.
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Introduction
Traditional medicine has been practiced since time immemorial by almost all cultures for treatment of
numerous human diseases in many parts of the world (Palombo 2006; Dasilva and Hoareau, 1999). About 80% of 
rural populations in Africa use traditional medicine, mostly plant preparations, for their primary healthcare (WHO 
2002-2005; Moshi 2005). About 20% of patients, who seek conventional medical care, first consult traditional 
healers (Dejong, 1991). In Kenya, like other African countries, traditional medicine is practiced by nearly all ethnic 
groups in the treatment of skin related problems, gastrointestinal diseases, sexually transmitted diseases, malaria, 
wounds, eye infections, measles and snake bites among others (Otieno et al., 2007;  Lukhoba et al.,  2006 ; Owuor 
and Kisangau, 2006 ; Mukiama, 2005 ; Kariba et al., 2001).
Gladiolus dalenii is one of the plants used by local communities in the Kenyan Lake Victoria Basin to treat 
various infections such as meningitis, malaria, diarrhoea, ulcers and HIV related fungal infections. Hot water extracts 
of freshly chopped or dried bulb is drunk to treat ulcers. Dried powdered bulb is sniffed to treat meningitis. A pinch 
of the same in water is drunk for the treatment of malaria and diarrhoea.
This study was carried out to establish the claimed therapeutic efficacy of G. dalenii against opportunistic fungal 
infections in HIV/AIDS patients with respect to A.niger.
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Materials and methods
Plant material 
The leaves and powdered bulb were collected from Chesikaki village in Bungoma, Kenya in September 
2007. The specimens were authenticated by a qualified plant taxonomist in the University of Nairobi, and a voucher 
specimen (SLO 308) deposited at Nairobi University Herbarium (NAI).
Microorganism
Aspergillus niger, a human fungal pathogen, was used in the susceptibility assays. Stocks were maintained 
on Sabourad’s Dextrose Agar (SDA) slants at 4°C prior to use for antifungal tests.
Preparation of crude extracts
20g of air dried powdered bulb was extracted by cold solvent percolation with dichloromethane/methanol 
(1:1) according to standard extraction methods (Harborne, 1998). The powdered plant material was mixed 
thoroughly with the solvent, left to stand for 24 hrs, and decanted (this was repeated twice). The filtrates were pooled 
and filtered using a Buchner funnel. After evaporation of the solvents, dichloromethane and methanol extracts were 
obtained. These were made up to desired weight/volume for bioassay analyses.
Preliminary screening for antifungal activity
Antifungal bioassay was carried out using disc diffusion method (Belboukhari and Cheriti, 2006). Discs cut 
from Whatman filter paper No.1 using a cock borer of diameter 1.2 cm were soaked for two hrs in each extract 
reconstituted with the extracting solvents serially diluted at concentration 1mg/100µl. The impregnated discs were 
then aseptically transferred into Sabourads Dextrose Agar (SDA) plates freshly inoculated with 0.5ml spore 
suspension of the test fungus. Griseofulvin and Ketoconazole antifungal drugs served as standards at similar 
concentrations, while discs impregnated with the extracting solvent served as controls. The plates were prepared in 
duplicates and then sealed with parafilm to avoid contamination and any possible drying up, and incubated in humid 
conditions at 25°C. The plates were observed for presence of zones of inhibition around the discs from day 3 to 5.
Direct Bioautography 
 In order to identify the active compound/s in each extract, commercially prepared Thin Layer 
Chromatography (TLC) plates made from silica gel were developed and the separated spots were seen visible under
the UV lamp. Freshly developed TLC plates were sprayed with previously prepared suspension of A .niger in
peptone media and incubated under humid conditions at 25°C (Hostettmann and Marston 1994; Horvath Gy et al.,
2002) and zones of inhibition noted.
Preliminary characterization of active compounds
Active CH2CL2 and MeOH extracts were tested for the presence or absence of five classes of compounds (Table
1) using appropriate spraying agents and UV detection according to Chowdhury et al., (2008) and Harborne, (1998).
Results and Discussion
Evaporation of the organic solvent yielded two extracts: Dichloromethane and Methanol soluble extracts. 
These were labelled as Ac1 and Ac2 respectively and antifungal activity tests carried out. 
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Table 2 showed that both the extracts and Ketoconazole (K), a commercial antifungal drug exhibited antifungal
activity against the test fungus while Griseofulvin (G) drug showed no activity. Ac2 showed higher activity than 
Ac1, whereas Ketoconazole showed the highest activity. 
Based on preliminary TLC screening by direct Bioautography and appropriate reagents, the active
antifungal compounds in both the test extracts were identified as alkaloids.
The petridishes with the extract Ac1 (Dichloromethane soluble extract), recorded delayed sporulation of the 
filamentous fungus up to day eight (8) whereas the plate containing methanol soluble extract (Ac2) had a dense 
sporulation of the fungus from day 5.
Table 1: Thin Layer Chromatography analyses of the antifungal compounds
Phytochemicals Spraying reagent Appearance of the positive spot.
Flavonoids 25% aqueous solution Basic lead acetate. Spots fluoresce in long-wave UV light.
Alkaloids Dragendorff Orange
Sapogenins Antimony chloride in concentrated hydrochloric acid. Violet. 
Terpenoids Antimony chloride in chloroform. Green 
Quinones Exposure to ammonia fumes. Red, orange, yellow, brown. 
(Adapted from Chowdhury et al., 2008.)
Table 2: % mean Inhibition zones of the extracts/drugs
Extract/ drug % mean inhibition 
CH2CL2 soluble extract (labeled Ac1) 69.44
MeOH soluble extract (Ac2) 75.00
Griseofulvin drug (G) 0.00???
Ketoconazole (K) 90.28
Negative Control  (C ) 12.50
Re-culturing and incubation of spores and mycelia from both the plates with the different extracts Ac1 and Ac2 
resulted into normal growth and sporulation. Regarding the incubation period and activity, there was no significant 
difference  (p value = 0.393) recorded in activities of the extracts as far as the incubation period was concerned, 
however in both the extracts, the mean percentage activity was highest on the 3rd day.
This study shows that CH2CL2and MeOH extracts of G. dalenii posses antifungal activity against A. niger. 
The opportunistic fungus appeared susceptible to activities of the extracts as shown by the large zones of inhibition
(Table 2.) at a concentration of 1mg/100µl. The delayed sporulation induced by dicholoromethane soluble extract 
was an interesting observation which has not been previously reported. Steenkamp et al., (2007) reported no activity 
of water and methanol bulb extracts of this plant against Staphylococcus aureus, and S. epidermidis bacteria; this was 
in contrast to reports by Fawole et al., (2008) who found out that dichloromethane extracts of this plant were active 
against Bacillus subtilis and S. aureus, while ethanol extracts were active against Candida albicans but inactive 
against Escherichia coli. Antiamoebic activity of bulb extracts of this plant has also been reported by Moundipa  et 
al., (2005). The antimicrobial activities reported confirm why extracts of this plant is used in traditional medicine to 
treat wounds, eye infections, ear infections, headache, dysentery, diarrhoea , stomach upset and gonorrhoea (Fawole 
et al., 2008 ; Yineger et al., 2008 ; Hutchings and Staden, 1994 ; Arnold and Gulumian, 1984 ). Burkill, (1985)
reported its usage in veterinary medicine. Other ethnomedicinal usage include treatement of arthritis, rheumatism, 
laxative, pains associated with menstruation, paralysis, convulsions, spasms, vermifuges, wound dressing, antidote 
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Figure 1: Antifungal activity of the two crude extracts from Gladiolus dalenii.  
Ac1- CH2CL2 solube extract; Ac2-  MeOH soluble extract; G- Griseofulvin;  
K- Ketoconazole; C- Negative Control,  
Figure 2 : Spore inhibitory properties of Ac1
Ac1- CH2CL2 solube extract,
 Ac2- MeOH soluble extract
A clear zone shown by the activity of Ac2A clear zone shown by the activity of Ac1
                                                                                
Dense sporulation by A.niger in 
plate with Ac2 extract
                                                                                
Lack of sporulation by A.niger in
 Plate with Ac1 extract
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against venomous snake and spider bites or stings and naso-pharyngeal infections. Burkill, (1985) also reported its
usage to make a drink, and as general food. In this regard, the activity of this plant and its ability to inhibit 
sporulation in A.niger may have been reported in this study for the first time. 
Significance of the results of this study is in the control of opportunistic fungus such as Aspergillus niger in 
immuno-compromised individuals. The fungal growth may be terminated completely at higher concentration of the 
active ingredient of this plant. Ability to delay sporulation as exhibited in these results is an indication that this plant 
has the potential to reduce allergies in susceptible individuals by ensuring no spores are produced. This finding 
suggests that extracts from G. dalenii could be used successfully for the management of Aspergillosis.
       Preliminary screening results show that alkaloids are responsible for the antifungal activity in this plant. 
This finding is partly in agreement with that of Burkill (1985) who reported that alkaloids are the main 
phytochemical component in this plant, but did not mention anything about the antifungal activity of this plant.
   
Conclusions and Recommendations
Results of this study indicate that it is important to carry out taxonomic verification and biochemical 
analysis studies on medicinal plants known to have ethnomedicinal uses. Further analysis of G. dalenii offers 
possibilities of developing plant-based compounds to help combat the lung problems caused by A. niger, one of the 
frequently encountered fungal infections in immunocompromised patients. Only in vitro methods were used in 
assessing the antifungal activity of the crude extracts of G. dalenii. Further investigation using bioassay guided 
fractionations to isolate and identify the pure compounds responsible for the antifungal activity and spore inhibitory 
ability are recommended. G. dalenii is a herb in nature and is able to grow fast, with the advantage of being an 
ornamental plant, possibilities of cultivation in large scale for commercial exploitation are recommended.
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